The results were consistent with a study in patients with rheumatoid arthritis, showing that tocilizumab treatment normalized the molecular signature at whole blood transcriptome levels to a greater extent than treatment with methotrexate or a tumor necrosis factor inhibitor [43]. This evidence concerns the gene TNF and rheumatoid arthritis.